Upper Respiratory Tract
Infection:
Pharmacotherapy
Dr. Pravin Prasad
MBBS, MD Clinical Pharmacology
Assistant Professor, Department of Clinical Pharmacology
Maharajgunj Medical Campus, Kathmandu
16 June 2020 (2 Asar 2077), Tuesday
1
By the end of this discussion, B. Pharm
3rd Year students will be able to:
List the conditions included in Upper respiratory tract infections
(URTIs)
List the aetiology of URTIs
Outline the pathophysiology of URTIs
List the clinical presentation of URTIs
Explain the therapeutic objectives for URTIs
Justify the role of pharmacotherapy in treatment of URTIs
2
Introduction
Infection of upper respiratory
tract common
Commonly includes:
Otitis media
Sinusitis
Pharyngitis
Also includes Rhinitis, Laryngitis
and Epiglottitis
3
Etiology and Pathophysiology: Otitis
media
Viral
Bacteria:
Streptococcus pneumoniae
Haemophilus influenzae
Moraxella catarrhalis
4
Clinical Presentation: Otitis media
History:
 Acute onset of signs and symptoms
Ear pain and fever
Children: irritable, tug on the involved ear, difficulty sleeping
Ear Examination:
Discolored (gray), thickened, bulging, eardrum
Immobile eardrum
Fluid coming from middle ear
Previous history of cold symptoms of runny nose, nasal congestion, or
cough
5
• Laboratory Tests:
• Gram stain, culture, and
sensitivities of draining or aspirated
fluid
Therapeutic Objectives: Otitis Media
Primary prevention of disease
Confirm the bacterial aetiology and provide antibiotics
Provide symptomatic relief
6
Therapeutic Options: Otitis media
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Stay away from cold
Do not put anything in the
ear
Do not blow nose forcefully
Drink warm fluids
7
Therapeutic Options: Otitis media
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Ear toileting
Cleaning the ear if
discharge present
Myringotomy
To drain the fluid in the
middle ear
As secondary prophylaxis
8
Therapeutic Options: Otitis media
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Vaccines
Seven valent pneumococcal
conjugate vaccine
Influenza vaccine
Pain management
Local anaesthesia (drops)
Oral analgesics
Antibiotics
9
Therapeutic Options: Otitis media
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
If complications develop
Mastoiditis,
Bacteremia
Meningitis
Auditory sequelae
10
Pharmacotherapy: Otitis media
Antibiotics
5-7 days, up to 14 days
Amoxicillin
High dose if resistant strept. Infection suspected
(90mg/kg/day)
Amoxicillin + Clavulanic acid
Resistant H. influenzae or M. catarrhalis suspected
Amoxicillin- 90mg/kg/day, Clavulanic acid- 6.4mg/kg/day
Intramuscular ceftriaxone, clindamycin, azithromycin,
11
• Can also be used for secondary
prophylaxis in recurrent infection
with seasonal variation
• Other option: Tympanostomy with
tube insertion
Aetiology and pathophysiology: Acute
bacterial sinusitis
Viral
Bacteria:
Streptococcus pneumoniae
Haemophilus influenzae
Moraxella catarrhalis
Uncommon: Streptococcus
pyogenes, Staphylococcus
aureus, fungi, anaerobes
12
Clinical Presentation: Acute Bacterial
Sinusitis
Signs and Symptoms
Nasal discharge/congestion
Maxillary tooth pain, facial or sinus pain that may radiate
(unilateral in particular), as well as deterioration after initial
improvement
Severe or persistent (>7 days) signs and symptoms: most likely
bacterial
Rhinorrhoea, chronic unproductive cough, laryngitis, headache
13
Therapeutic Objective: Acute Bacterial
Sinusitis
Reduce signs and symptoms
Achieve and maintain patency of the ostia,
Eradicate the bacterial infection
Minimize the duration of illness
Prevent complications and progression to chronic disease
14
Therapeutic Options: Acute Bacterial
Sinusitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Use mask
Avoid dust and cold
Do not blow nose forcefully
Drink warm fluids
15
Therapeutic Options: Acute Bacterial
Sinusitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Steam Inhalation
Irrigation of nasal cavity with
saline
16
Therapeutic Options: Acute Bacterial
Sinusitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Antibiotics
Decongestants
Local
Oral
17
Therapeutic Options: Acute Bacterial
Sinusitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
If complications develop
Mental status changes
Immunosuppressive illness,
significant coexisting illnesses, risk
factors for β -lactam-resistant
strains
Isolated frontal or sphenoid
sinusitis, or intense periorbital
swelling, erythema, and facial pain
Unilateral findings
History of antibiotic failure
18
Decongestants in Acute Bacterial
Sinusitis
Helps by decreasing nasal blockade and improve aeration to
sinuses
Acts by causing vasoconstriction
Local decongestants: oxymetazoline, phenylephrine
Oral decongestants: pseudoephedrine, phenylephrine
Intra-nasal glucocorticoids
Antihistamines: NOT recommended
19
Antibiotics: Acute Bacterial Sinusitis
20
Aetiology: Acute Pharyngitis
Viruses
Rhinovirus
Coronavirus
Influenza, parainfluenza virus
Adenovirus
Herpes simplex virus, Epstein-
Barr virus
Bacteria
Group A beta haemolytic
Streptococci (S. pyogens,
GABHS)
Others:
C and G Streptococcus,
Corynebacterium diphtheriae,
Neisseria gonorrhoeae,
Mycoplasma pneumoniae,
Arcanobacterium
haemolyticum, Yersinia
enterocolitica, and Chlamydia 21
Aetiology and Pathophysiology: Acute
Pharyngitis
22
Asymptomatic
carrier (GABHS)
Altered host
immunity
• Invasion of pharyngeal mucosa
• Colonisation of mucosa with
bacteria
Clinical Presentation: Acute Pharyngitis
Signs and Symptoms
Sore throat, Pain on swallowing
Fever, headache, nausea, vomiting, and abdominal pain
Conjunctivitis, Coryza, Cough, Diarrhoea
Suggestive of Viral Pharyngitis
23
Clinical Presentation: Acute Pharyngitis
Local Examination:
Erythema/inflammation of the tonsils, pharynx +/- patchy
exudates
Enlarged, tender lymph nodes
Red swollen uvula, petechiae on the soft palate
Laboratory Tests:
 Throat swab and culture
Rapid antigen detection testing (RADT)
24
Therapeutic Objectives: Acute
Pharyngitis
Improve clinical signs and symptoms
Minimize adverse drug reactions
Prevent transmission to close contacts,
Prevent acute rheumatic fever and suppurative complications
25
Therapeutic Options: Acute Pharyngitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Avoid cold
Do not shout or scream
Drink warm fluids
Use mask
26
Therapeutic Options: Acute Pharyngitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Non-prescription lozenges
and sprays
Menthol
Topical anaesthetics
Tonsillectomy
27
Therapeutic Options: Acute Pharyngitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
Antipyretic, analgesic
management
Acetaminophen
Antibiotics
28
Therapeutic Options: Acute Pharyngitis
General information and
advice
Non pharmacological therapy
Pharmacological therapy
Referral therapy
If suppurative complications
develops
29
Antibiotics: Acute Pharyngitis
Benzathine Penicillin
Amoxicillin in children
Penicillin allergic patients:
Cephalosporins (Cefalexin), Macrolides (Erythromycin,
Azithromycin)
Macrolide resistant: Clindamycin
Recurrent episodes: Amoxicillin-clavulanic acid, clindamycin
Chronic prophylaxis: benzathine penicillin, sulfadiazine 30
Antibiotics: Acute Pharyngitis
31
Conclusion
URTIs commonly includes otitis media, sinusitis and pharyngitis
Viral causes are more common aetiology for URTIs
Blockade of normal drainage is critical in development of Otitis media and
Sinusitis; host compromise in critical for pharyngitis
Symptoms are commonly local and are associated with systemic signs
Control of bacterial infection is pivotal for the management of URTIs
Due to better efficacy, safety, cost-effectiveness and experience, penicillins
are preferred for treatment of URTIs
32
Questions??
33

Upper respiratory tract infection pharmacotherapy

  • 1.
    Upper Respiratory Tract Infection: Pharmacotherapy Dr.Pravin Prasad MBBS, MD Clinical Pharmacology Assistant Professor, Department of Clinical Pharmacology Maharajgunj Medical Campus, Kathmandu 16 June 2020 (2 Asar 2077), Tuesday 1
  • 2.
    By the endof this discussion, B. Pharm 3rd Year students will be able to: List the conditions included in Upper respiratory tract infections (URTIs) List the aetiology of URTIs Outline the pathophysiology of URTIs List the clinical presentation of URTIs Explain the therapeutic objectives for URTIs Justify the role of pharmacotherapy in treatment of URTIs 2
  • 3.
    Introduction Infection of upperrespiratory tract common Commonly includes: Otitis media Sinusitis Pharyngitis Also includes Rhinitis, Laryngitis and Epiglottitis 3
  • 4.
    Etiology and Pathophysiology:Otitis media Viral Bacteria: Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis 4
  • 5.
    Clinical Presentation: Otitismedia History:  Acute onset of signs and symptoms Ear pain and fever Children: irritable, tug on the involved ear, difficulty sleeping Ear Examination: Discolored (gray), thickened, bulging, eardrum Immobile eardrum Fluid coming from middle ear Previous history of cold symptoms of runny nose, nasal congestion, or cough 5 • Laboratory Tests: • Gram stain, culture, and sensitivities of draining or aspirated fluid
  • 6.
    Therapeutic Objectives: OtitisMedia Primary prevention of disease Confirm the bacterial aetiology and provide antibiotics Provide symptomatic relief 6
  • 7.
    Therapeutic Options: Otitismedia General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Stay away from cold Do not put anything in the ear Do not blow nose forcefully Drink warm fluids 7
  • 8.
    Therapeutic Options: Otitismedia General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Ear toileting Cleaning the ear if discharge present Myringotomy To drain the fluid in the middle ear As secondary prophylaxis 8
  • 9.
    Therapeutic Options: Otitismedia General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Vaccines Seven valent pneumococcal conjugate vaccine Influenza vaccine Pain management Local anaesthesia (drops) Oral analgesics Antibiotics 9
  • 10.
    Therapeutic Options: Otitismedia General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy If complications develop Mastoiditis, Bacteremia Meningitis Auditory sequelae 10
  • 11.
    Pharmacotherapy: Otitis media Antibiotics 5-7days, up to 14 days Amoxicillin High dose if resistant strept. Infection suspected (90mg/kg/day) Amoxicillin + Clavulanic acid Resistant H. influenzae or M. catarrhalis suspected Amoxicillin- 90mg/kg/day, Clavulanic acid- 6.4mg/kg/day Intramuscular ceftriaxone, clindamycin, azithromycin, 11 • Can also be used for secondary prophylaxis in recurrent infection with seasonal variation • Other option: Tympanostomy with tube insertion
  • 12.
    Aetiology and pathophysiology:Acute bacterial sinusitis Viral Bacteria: Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis Uncommon: Streptococcus pyogenes, Staphylococcus aureus, fungi, anaerobes 12
  • 13.
    Clinical Presentation: AcuteBacterial Sinusitis Signs and Symptoms Nasal discharge/congestion Maxillary tooth pain, facial or sinus pain that may radiate (unilateral in particular), as well as deterioration after initial improvement Severe or persistent (>7 days) signs and symptoms: most likely bacterial Rhinorrhoea, chronic unproductive cough, laryngitis, headache 13
  • 14.
    Therapeutic Objective: AcuteBacterial Sinusitis Reduce signs and symptoms Achieve and maintain patency of the ostia, Eradicate the bacterial infection Minimize the duration of illness Prevent complications and progression to chronic disease 14
  • 15.
    Therapeutic Options: AcuteBacterial Sinusitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Use mask Avoid dust and cold Do not blow nose forcefully Drink warm fluids 15
  • 16.
    Therapeutic Options: AcuteBacterial Sinusitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Steam Inhalation Irrigation of nasal cavity with saline 16
  • 17.
    Therapeutic Options: AcuteBacterial Sinusitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Antibiotics Decongestants Local Oral 17
  • 18.
    Therapeutic Options: AcuteBacterial Sinusitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy If complications develop Mental status changes Immunosuppressive illness, significant coexisting illnesses, risk factors for β -lactam-resistant strains Isolated frontal or sphenoid sinusitis, or intense periorbital swelling, erythema, and facial pain Unilateral findings History of antibiotic failure 18
  • 19.
    Decongestants in AcuteBacterial Sinusitis Helps by decreasing nasal blockade and improve aeration to sinuses Acts by causing vasoconstriction Local decongestants: oxymetazoline, phenylephrine Oral decongestants: pseudoephedrine, phenylephrine Intra-nasal glucocorticoids Antihistamines: NOT recommended 19
  • 20.
  • 21.
    Aetiology: Acute Pharyngitis Viruses Rhinovirus Coronavirus Influenza,parainfluenza virus Adenovirus Herpes simplex virus, Epstein- Barr virus Bacteria Group A beta haemolytic Streptococci (S. pyogens, GABHS) Others: C and G Streptococcus, Corynebacterium diphtheriae, Neisseria gonorrhoeae, Mycoplasma pneumoniae, Arcanobacterium haemolyticum, Yersinia enterocolitica, and Chlamydia 21
  • 22.
    Aetiology and Pathophysiology:Acute Pharyngitis 22 Asymptomatic carrier (GABHS) Altered host immunity • Invasion of pharyngeal mucosa • Colonisation of mucosa with bacteria
  • 23.
    Clinical Presentation: AcutePharyngitis Signs and Symptoms Sore throat, Pain on swallowing Fever, headache, nausea, vomiting, and abdominal pain Conjunctivitis, Coryza, Cough, Diarrhoea Suggestive of Viral Pharyngitis 23
  • 24.
    Clinical Presentation: AcutePharyngitis Local Examination: Erythema/inflammation of the tonsils, pharynx +/- patchy exudates Enlarged, tender lymph nodes Red swollen uvula, petechiae on the soft palate Laboratory Tests:  Throat swab and culture Rapid antigen detection testing (RADT) 24
  • 25.
    Therapeutic Objectives: Acute Pharyngitis Improveclinical signs and symptoms Minimize adverse drug reactions Prevent transmission to close contacts, Prevent acute rheumatic fever and suppurative complications 25
  • 26.
    Therapeutic Options: AcutePharyngitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Avoid cold Do not shout or scream Drink warm fluids Use mask 26
  • 27.
    Therapeutic Options: AcutePharyngitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Non-prescription lozenges and sprays Menthol Topical anaesthetics Tonsillectomy 27
  • 28.
    Therapeutic Options: AcutePharyngitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy Antipyretic, analgesic management Acetaminophen Antibiotics 28
  • 29.
    Therapeutic Options: AcutePharyngitis General information and advice Non pharmacological therapy Pharmacological therapy Referral therapy If suppurative complications develops 29
  • 30.
    Antibiotics: Acute Pharyngitis BenzathinePenicillin Amoxicillin in children Penicillin allergic patients: Cephalosporins (Cefalexin), Macrolides (Erythromycin, Azithromycin) Macrolide resistant: Clindamycin Recurrent episodes: Amoxicillin-clavulanic acid, clindamycin Chronic prophylaxis: benzathine penicillin, sulfadiazine 30
  • 31.
  • 32.
    Conclusion URTIs commonly includesotitis media, sinusitis and pharyngitis Viral causes are more common aetiology for URTIs Blockade of normal drainage is critical in development of Otitis media and Sinusitis; host compromise in critical for pharyngitis Symptoms are commonly local and are associated with systemic signs Control of bacterial infection is pivotal for the management of URTIs Due to better efficacy, safety, cost-effectiveness and experience, penicillins are preferred for treatment of URTIs 32
  • 33.

Editor's Notes

  • #4 Otitis media (Middle ear infection) Sinusitis (Infection of paranasal sinuses) Pharyngitis Rhinitis (Nose infection) Laryngitis Epiglottitis
  • #6 Acute onset of signs and symptoms of middle ear infection following cold symptoms of runny nose, nasal congestion, or cough
  • #14 Maxillary tooth pain, facial or sinus pain that may radiate (unilateral in particular), as well as deterioration after initial improvement Children: Nasal discharge and cough for longer than 10 to 14 days or severe signs and symptoms such as temperature above 39°C (102°F) or facial swelling or pain are indications for antibiotic therapy Chronic Symptoms are similar to acute sinusitis but more nonspecific Rhinorrhea is associated with acute exacerbations Chronic unproductive cough, laryngitis, and headache may occur Chronic/recurrent infections occur three or four times per year and are unresponsive to steam and decongestants
  • #15 Reduce signs and symptoms, Achieve and maintain patency of the ostia, Limit antibiotic treatment to those who may benefit Eradicate the bacterial infection with appropriate antibiotic therapy, Minimize the duration of illness, prevent complications, and prevent progression from acute disease to chronic disease.
  • #24 General A sore throat of sudden onset that is mostly self-limited Fever and constitutional symptoms resolving in about 3 to 5 days Clinical signs and symptoms are similar for viral causes and nonstreptococcal bacterial causes
  • #25 General A sore throat of sudden onset that is mostly self-limited Fever and constitutional symptoms resolving in about 3 to 5 days Clinical signs and symptoms are similar for viral causes and nonstreptococcal bacterial causes
  • #26 suppurative complications, such as peritonsillar abscess, cervical lymphadenitis, and mastoiditis.
  • #31 Patients with documented histories of rheumatic fever (including cases manifested solely by Sydenham chorea) and those with definite evidence of rheumatic heart disease should receive continuous prophylaxis initiated as soon as the patient is diagnosed and the initial infection has been treated. The duration of secondary prophylaxis is individualized based on patient risk of recurrence of rheumatic fever and/or rheumatic heart disease. Intramuscular benzathine penicillin G every 4 weeks is the recommended regimen for secondary prevention in the United States in most circumstances. Additional options for secondary prophylaxis include oral penicillin V and sulfadiazine. Medication adherence is key to successful secondary prevention